A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)
帕博利珠单抗作为二线疗法治疗中国晚期或转移性黑色素瘤患者的 Ib 期研究 (KEYNOTE-151)
期刊:Translational Oncology
影响因子:4.1
doi:10.1016/j.tranon.2019.02.007
Si, Lu; Zhang, Xiaoshi; Shu, Yongqian; Pan, Hongming; Wu, Di; Liu, Jiwei; Lou, Fang; Mao, Lili; Wang, Xuan; Wen, Xizhi; Gu, Yanhong; Zhu, Lingjun; Lan, Shijie; Cai, Xin; Diede, Scott J; Zhou, Yu; Ge, Jun; Li, Jianfeng; Wu, Haiyan; Guo, Jun